Absci Corp - ABSI Company Long-Term Liabilities

Brandmark of Absci Corp (ABSI)

Absci (ABSI) leverages AI solutions for drug discovery supported by diversified reagent supplies and server infrastructure. Strategic alliances with pharmaceutical behemoths sustain the company's stability and reduce biologics costs. This price chart, which assists in the asset's baseline valuation, shows the metric at 0.00. Technological superiority is driven by a powerful R&D center developing a machine learning platform for antibody synthesis.

ABSI Absci Corp: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Summary analytical data breakdowns for Absci Corp. (ABSI)

- price and consensus price forecast:
Price Performance Chart absci.com|ABSI - Price Target Chart
- market capitalization data:
Market Valuation Absci|ABSI - Enterprise Value
- book capitalization data:
Net Asset Value per Share Absci|ABSI - Book Capitalization|Capitalization to Book Value Ratio absci.com|ABSI - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Absci|ABSI - Long-Term Debt to Capital|Short-Term Debt to Equity Absci Bio|ABSI - Company Debts|Debts to Net Assets Absci|ABSI - Company Long-Term Debts|Company Current Liabilities Absci
General company analysis:ABSI (absci.com)
Original product of Absci Bio

Analyzing long-term liabilities is critical for assessing the financial stability of Absci (ABSI) when calculating leverage multiples. The company's long-term debt trend reflects the aggregate of loans with maturities exceeding one year, allowing investors to filter out market noise. An increase in this metric for Absci (ABSI) signifies the raising of capital to fund expansion within the AI-driven antibody development sector. Investors should correlate debt dynamics with the pace of securing strategic contracts with pharmaceutical behemoths.

Competitor analysis for Absci

veeva.com - Company Long-Term Loans and Borrowings|DOCS: Company Long-Term Debt|HQY - Company Long-Term Liabilities|Company Long-Term Debts WAY|CorVel Corp. (CRVL) - Long-Term Debt|Company Long-Term Debts Privia Health Group (PRVA)|Company Long-Term Indebtedness huronconsultinggroup.com|Company Long-Term Debts CERT|Company Long-Term Debts Omnicell Inc (OMCL)|Company Long-Term Debts GoodRx Corp GDRX|Schrodinger Corp - Company Long-Term Debt|Company Long-Term Debt PHR (Phreesia, Inc.)|OMDA - Long-Term Debt Volume|EVH (Evolent Health) - Company Long-Term Debts|HealthStream Inc (HSTM) - Company Long-Term Liabilities|DH: Company Long-Term Debts|Long-Term Debt Volume Consensus Corp|Company Long-Term Debts AGL|Company Long-Term Debts soyoung.com (SY)|Company Long-Term Debts National Research Corp NRC|Spok Holdings Inc - Company Long-Term Debt|Company Long-Term Debt OPRX (OptimizeRx Corp.)|TBRG - Long-Term Debt Volume|Simulations Plus, Inc. - Company Long-Term Debts|SOPHiA GENETICS (SOPH) - Long-Term Debt Volume|HCAT: Company Long-Term Debts|Long-Term Debt Volume CareCloud Corp (CCLD)|Company Long-Term Liabilities Research Solutions|Amount of Long-Term Liabilities dlhcorp.com DLHC|Company Long-Term Liabilities OneMedNet|scienture.com - Company Long-Term Loans and Borrowings|HCTI: Company Long-Term Debt|ISPC - Company Long-Term Liabilities|Company Long-Term Debts BFRG|SCWorx Inc (WORX) - Long-Term Debt|Company Long-Term Debts MSP Recovery Inc (MSPR)|Company Long-Term Indebtedness iCoreConnect Corp|Company Long-Term Debts MEDS|Company Long-Term Debts Orgenesis Inc (ORGS)|Company Long-Term Debts R1 RCM RCM|Sharecare Inc - Company Long-Term Debt|Company Long-Term Debt STRM (Streamline Health Solutions)|SYRA - Long-Term Debt Volume|AMEH (apollomed.net) - Company Long-Term Debts|Model N Inc (MODN) - Company Long-Term Liabilities|NXGN: Company Long-Term Debts